ROHHAD syndrome presents a significant resemblance to HIDEA syndrome. The latter is caused by biallelic loss-of-function variants in the gene and encompasses hypotonia, intellectual disabilities, eye abnormalities, hypoventilation, and dysautonomia. We report the first patient identified with HIDEA syndrome from our ROHHAD cohort. Our patient was a 21-month-old girl who had a history of severe respiratory infections requiring intensive care, hypotonia, abnormal eye movements, and rapid weight gain. Polysomnography identified severe central hypoventilation. During her follow-up, a significant psychomotor delay and the absence of language were gradually observed. The prolactin levels were initially increased. Hypothermia was reported at 4 years. Exome sequencing identified a new homozygous truncating variant. Our patient met the diagnosis criteria for ROHHAD, which included rapid weight gain, central hypoventilation appearing after 1.5 years of age, hyperprolactinemia suggesting hypothalamic dysfunction, and autonomic dysfunction manifesting as strabismus and hypothermia. However, she also presented with severe neurodevelopmental delay, which is not a classic feature of ROHHAD syndrome. HIDEA syndrome presents similarities with ROHHAD, including hypoventilation, obesity, and dysautonomia. To date, only 14% of endocrinological disturbances have been reported in HIDEA patients. Better delineation of both syndromes is required to investigate the eventual involvement of , a regulator of calcium dynamics and gliotransmission, in ROHHAD patients. In the case of clinical evidence of ROHHAD in a child with abnormal neurological development or eye abnormalities, we suggest that the gene be systematically interrogated in addition to the analysis of the gene. A better delineation of the natural history of HIDEA is required to allow further comparisons between features of HIDEA and ROHHAD. The clinical similarities could potentially orient some molecular hypotheses in the field of ROHHAD research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073441PMC
http://dx.doi.org/10.3389/fgene.2023.1137767DOI Listing

Publication Analysis

Top Keywords

hidea syndrome
16
rohhad syndrome
12
rohhad
10
similarities rohhad
8
syndrome rohhad
8
syndrome presents
8
eye abnormalities
8
rapid weight
8
weight gain
8
central hypoventilation
8

Similar Publications

Background: HIDEA syndrome (MIM: #618493) is a rare autosomal recessive disorder characterized by hypotonia, hypoventilation, intellectual disability, dysautonomia, epilepsy, and eye anomalies. We present the case of a Turkish female with developmental and epileptic encephalopathy, highlighting a novel compound heterozygous variation in the P4HTM gene.

Case Presentation: A 6-year and 11-month-old girl with early infantile epileptic encephalopathy and abnormal eye movements since the neonatal period has been presented to our clinic.

View Article and Find Full Text PDF

The gene encodes a transmembrane prolyl 4-hydroxylase, which is responsible for the degradation of hypoxia-inducible transcription factors (HIF) under normoxia. Clinically, biallelic variants have been identified in patients with hypotonia, hypoventilation, intellectual disabilities, dysautonomia, epilepsy, and eye abnormalities (HIDEA syndrome). Seizure was one of the most prominent symptoms.

View Article and Find Full Text PDF

A pathogenic P4HTM gene variant in two brothers with autism spectrum disorder.

Psychiatr Genet

April 2024

Department of Child and Adolescent Psychiatry, Elazig Fethi Sekin City Hospital, Elazig, Turkey.

Autism spectrum disorder is a neurodevelopmental condition that involves limitations in social communication and various stereotypical repetitive behaviors. Genetic and environmental factors both play a role in the etiology. Numerous genetic syndromes accompanying autism spectrum disorders have been reported.

View Article and Find Full Text PDF

Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.

Pflugers Arch

September 2024

Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, Aapistie 7C, P.O. Box 5400, 90014, Oulu, Finland.

Article Synopsis
  • Transmembrane prolyl 4-hydroxylase (P4H-TM) is an enzyme linked to severe neurological issues such as HIDEA syndrome, characterized by conditions like hypotonia and intellectual disability.
  • Research on P4h-tm mice revealed significant changes in their energy and glucose metabolism, including altered physical activity and muscle weakness compared to wild-type mice.
  • While the exact causes of these changes are not fully understood, the altered physiology in P4h-tm mice mirrors symptoms seen in HIDEA patients, indicating this model could help develop targeted therapies.
View Article and Find Full Text PDF

HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome.

Front Genet

March 2023

Human Genetics Department, CHU of Liège, Liège, Belgium.

ROHHAD syndrome presents a significant resemblance to HIDEA syndrome. The latter is caused by biallelic loss-of-function variants in the gene and encompasses hypotonia, intellectual disabilities, eye abnormalities, hypoventilation, and dysautonomia. We report the first patient identified with HIDEA syndrome from our ROHHAD cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!